Physician profile
Stuart M Feldman
NPI 1568685758
$34,473.34
in general payments reported to CMS, 2019-2025
19 companies · $553 in 2025
The $553 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $370 · 2021: $3,302 · 2022: $29K · 2023: $464 · 2024: $290 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,307.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $32,018.36 | 2020-2024 | Collagenase Santyl |
| Melinta Therapeutics, LLC | $1,106.48 | 2021-2025 | Kimyrsa, Rezzayo |
| Paratek Pharmaceuticals, INC. | $249.00 | 2022-2025 | Nuzyra |
| Nevro Corp. | $214.53 | 2021-2023 | Senza |
| Allergan, INC. | $196.56 | 2019-2020 | |
| Stryker Corporation | $149.88 | 2023 | Hoffmann |
| Abbvie INC. | $94.42 | 2021-2025 | |
| Novo Nordisk INC | $76.24 | 2019 | |
| Merck Sharp & Dohme LLC | $66.01 | 2019 | |
| Horizon Therapeutics Plc | $46.66 | 2021-2022 | |
| Boston Scientific Corporation | $39.85 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $39.06 | 2023 | Seglentis |
| Orthofix Medical, INC. | $38.22 | 2021-2024 | Physio-Stim |
| Organogenesis INC. | $30.82 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $27.88 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24.34 | 2025 | Venaseal |
| Hartmann USA, INC. | $22.59 | 2025 | Zetuvit Plus 10x10 P10 |
| Nalu Medical, INC. | $18.45 | 2021 | |
| Cardiovascular Systems INC. | $13.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.